QUOTED. Moshe Shoham.

May 17 2022

Listen to this article

Medtech Insight talked with Moshe Shoham about the innovative technologies and successful medical robotics companies, like Mazor Robotics, that were spun out of his lab at the Technion Institute. See what Shoham said about the future of robotic-assisted surgeries.

Quoted Column

“There are some things that a robot can do better than a human and we are going to give them the jobs to do where they excel. The design of the surgery and the decisions are made by surgeons and that will remain for years. Maybe at some point when we have enough machine learning and data, maybe then the decisions will be made by robots.” – Moshe Shoham, head of medical robotics laboratory, Technion-Israel Institute of Technology

Find out more: Exec Chat: Israel’s Authority On Medical Robotics Lifts Curtain Behind Technion’s Success Stories

More from Digital Technologies

Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Immersive Gaming; DHCoE AI Framework; Hello Heart
Dec 08 2025
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people recover from serious brain injuries. Elizabeth Orr introduces new voting members of the new Digital Health Advisory Committee and Natasha Barrow discusses Hello Heart’s new symptom-tracking feature in their heart-focused app.
News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards
Sep 30 2025
This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.
MI-DigitalTechnologies (Premium-1): Optimal Imaging Frequency After Spine SBRT: Balancing Surveillance and Patient Care
Jun 14 2025
• By Nabil
A Deep Dive into Evidence-Based Guidelines, Clinical Considerations, and Evolving Practices for Post-SBRT Imaging in Spinal Tumor Patients
J&J MedTech Keeps Up Cardiovascular Momentum With Shockwave E8 Launch In US
Sep 25 2024
Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.

More from Medtech Insight

Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says - Clone
May 22 2026
• By Elizabeth Orr
AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.
US Original PMAs and Panel-Track Supplementss
Feb 23 2026
• By Olga Zviezdicheva, Reed Miller, and Nabil
Class III devices and panel-track supplements approved by US FDA’s Center for Devices and Radiological Health. Data derived from FDA.gov. Updated weekly.
Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says
Jan 23 2026
• By Elizabeth Orr
AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.